Pitofsky Jason 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2026/2/11 申報
- 申報編號
- 0002009236-26-000001
- 申報時間
- 2026/2/11
- 交易日
- 2026/2/9
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 12 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $158.5 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Pitofsky JasonCIK 0002009236 | 高階主管（SVP Controller） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/2/9 | Common Stock | M行使選擇權取得 | +1,000 | $492.00 | +$492,000 | 6,308 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −20 | $775.95 | −$15,519 | 6,288 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −521 | $776.43F2 | −$404,520.03 | 5,767 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −391 | $777.51F3 | −$304,006.41 | 5,376 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −563 | $778.35F4 | −$438,211.05 | 4,813 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −205 | $779.56F5 | −$159,809.8 | 4,608 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −75 | $780.06F6 | −$58,504.5 | 4,533 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −26 | $781.37F7 | −$20,315.62 | 4,507 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −37 | $782.67F8 | −$28,958.79 | 4,470 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −144 | $783.23F9 | −$112,785.12 | 4,326 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −1 | $784.66 | −$784.66 | 4,325 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −53 | $785.72F10 | −$41,643.16 | 4,272 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/2/9 | Common Stock | M行使選擇權處分 | −1,000 | $0.00 | $0 | 905 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 521 shares of Company stock on February 9, 2026 at prices ranging from $776.05 to $776.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 391 shares of Company stock on February 9, 2026 at prices ranging from $777.33 to $777.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 563 shares of Company stock on February 9, 2026 at prices ranging from $778.00 to $778.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 205 shares of Company stock on February 9, 2026 at prices ranging from $779.19 to $779.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 75 shares of Company stock on February 9, 2026 at prices ranging from $780.03 to $780.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 26 shares of Company stock on February 9, 2026 at prices ranging from $781.18 to $781.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 37 shares of Company stock on February 9, 2026 at prices ranging from $782.22 to $782.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents volume-weighted average price of sales of 144 shares of Company stock on February 9, 2026 at prices ranging from $783.17 to $783.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F10
Represents volume-weighted average price of sales of 53 shares of Company stock on February 9, 2026 at prices ranging from $785.72 to $785.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。